Continuous Positive Airway Pressure CPAP Devices Market : Current Analysis and Forecast (2020-2026): Emphasis on Automation (Manual CPAP Devices, Automatic CPAP Devices); Component (CPAP Motors, CPAP Humidifier, CPAP Masks, CPAP Other Accessories); Application (Sleep Apnea, COPD, Others Diseases); End-User (Hospitals & Clinics, Home Care, Others (Sleep laboratories)) and Region and Country
- UNI4065923
- 166 Pages
- July 2020
- Healthcare
Apart from the above-mentioned factors, the world is suffering from a major crisis due to the shortage of ventilators for the treatment of COVID-19. Continuous Positive Airway Pressure (CPAP) Devices are used in hospitals as this equipment can help the patients suffering from mild COVID-19. Rising demand for home care will increase the adoption of these devices as they can be operated in the home settings easily. However, the high cost of device and maintenance and poor adherence to CPAP will act as a restraint for the market growth. 3B Medical, Inc., Philips Respironics, Nidek medical, ResMed, Fisher and Paykel Healthcare, Teijin Pharma Limited, Drive Medical, Fosun Pharma, Koike Medical and BMC Medical Corporation are some of the prominent players operating in the Global Continuous Positive Airway Pressure (CPAP) Devices market. Several M&A’s along with partnerships have been undertaken by these players to facilitate costumers with hi-tech and innovative products.
Insights Presented in the Report
“Amongst Automation, Manual CPAP devices dominated the market in 2019, accounting for 69.4% share”
Based on Automation, the global CPAP devices market is segmented into manual and automated devices. Both are used for treating sleep apnea. However, Automatic CPAP (APAP) devices are designed to adjust the amount of pressure automatically that is delivered to the patient to breathe by breathe basis. Owing to this Automatic CPAP (APAP) devices are expected to witness the highest CAGR of 11.23% during the forecast period 2021-2026.
“CPAP Motor dominated the component segment market of the global CPAP Devices market in 2019”
Based on components, the global CPAP devices market is segmented into CPAP motors, CPAP humidifiers, CPAP masks and other CPAP accessories including filters and hoses, etc. CPAP Motors dominated the market, generating revenue of US$ 1,159.3 million in 2019. The major change has been observed in the CPAP mask since the invention of the device as earlier masks used to cover the entire face thus, making it difficult for the patients. Currently, CPAP masks are more comfortable and cover less area. CPAP Masks is expected to witness a CAGR growth of 9.44% during the analyzed period.
“CPAP devices are majorly used for Sleep Apnea disorder. The segment accounted for 53.7% revenue share in 2019”
Based on application, the global CPAP devices market is segmented into sleep apnea, COPD and other disorders. CPAP Device application in treating sleep apnea covered the major market share. The rising prevalence of sleep apnea due to increasing obesity rates and rising elderly population will further increase the adoption of CPAP devices for the treatment of sleep apnea disorder.
Continuous Positive Airway Pressure Devices Market Size by Application, Global 2019-2026 (US$ Million)
“Amongst End-User, Hospitals & Clinics are the major adopter of CPAP devices for disease treatment”
Based on End-User, the global CPAP devices market is segmented into hospitals & clinics, home setting and sleep laboratories. Demand for Continuous Positive Airway Pressure (CPAP) devices is highest in the hospitals and clinics due to the rising COVID-19 cases. This equipment is also utilized in the Neonatal Intensive Critical Unit (NICU) for providing support to the neonates who are born with underdeveloped lungs. Moreover, the increasing popularity of homecare will further increase market growth.
“North America dominated the global CPAP devices market and is expected to generate revenue of US$ 1,447.8 million in 2026”
For a better understanding on the market dynamics of the global Continuous Positive Airway Pressure (CPAP) Devices market, a detailed analysis was conducted for different regions and country including North America (the U.S and Canada), Europe (Germany, France, Spain, Italy, and United Kingdom), Asia-Pacific (China, Japan, India, and Australia) and rest of the world has been conducted. In 2020, North America is expected to generate the highest revenue share, owing to increased COVID-19 cases in the United States. Further, it is estimated that the US has the largest market for Continuous Positive Airway Pressure (CPAP) Devices due to the high awareness among sleep apnea patients.
Competitive Landscape
3B Medical, Inc., Philips Respironics, Nidek medical, ResMed, Fisher and Paykel Healthcare, Teijin Pharma Limited, Drive Medical, Fosun Pharma, Koike Medical and BMC Medical are some of the prominent players operating in the Global Household Cleaning Product market. Several M&A’s along with partnerships have been undertaken by these players to facilitate costumers with more efficient and innovative products.
Reasons to buy this report:
• The study includes market sizing and forecasting analysis validated by authenticated key industry experts
• The report presents a quick review of overall industry performance at one glance
• The report covers in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
• Detailed examination of drivers, restraints, key trends and opportunities prevailing in the industry
• The study comprehensively covers the market across different segments
• Deep dive regional level analysis of the industry
Customization Options:
Continuous Positive Airway Pressure (CPAP) Devices Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
1.1 Market Definition 15
1.2 Objective of the Study 15
1.3 Limitation 15
1.4 Stakeholders 16
1.5 Currency used in the Report 16
1.6 Scope of the Global CPAP Device Market Study 16
2. RESEARCH METHODOLOGY OR ASSUMPTION 17
2.1 Research Methodology for the Global CPAP device Market Study 17
2.1.1 Main objective of the Global CPAP device Market Study 18
3. INDUSTRY PERFORMANCE 19
4. EXECUTIVE SUMMARY 21
5. REGULATORY FRAMEWORK OF CPAP DEVICES 23
5.1 United States 23
5.2 Canada 24
6. MARKET OVERVIEW 26
6.1 Introduction 26
6.1.1 Market Trend & Drivers 26
6.1.1.1 Rising Prevalence of Sleeping Disorders 26
6.1.1.2 Greater Incidence of Sleep Apnea in Elderly Population 26
6.1.1.3 Increasing Demand for CPAP-therapy 27
6.1.1.4 Increasing Sales through E-Commerce 28
6.1.2 Market Restraints 29
6.1.2.1 High Cost of Device and Maintenance 29
6.1.2.2 Poor Adherence to CPAP 29
6.1.3 Market Trend 29
6.1.3.1 Rising Demand for Home Care 29
6.1.3.2 Infrastructural Advancements in the Medical and Healthcare Industry 30
7. CPAP USAGE IN THE COVID-19 TREATMENT 32
7.1 Approval of Usage of CPAP as COVID-19 Treatment 32
7.2 Managing the Demand during COVID-19 32
8. DEMAND AND SUPPLY SIDE ANALYSIS 34
8.1 Demand Side Analysis 34
8.2 Supply Side Analysis 35
8.2.1 Top Product Launches 35
8.2.2 Top Partnerships 37
8.2.3 Top Mergers & Acquisitions 38
8.2.4 Top Business Expansions, Investment and Divestitures 39
9. CPAP DEVICE MARKET VALUE CHAIN 40
9.1 Key-Value Chain Analysis 40
10. MARKET INSIGHTS BY AUTOMATION 41
10.1 General Overview 41
10.1.1 Manual CPAP Devices 42
10.1.2 Automatic CPAP Devices 43
11. MARKET INSIGHTS BY COMPONENT 44
11.1 General Overview 44
11.1.1 CPAP Motors 45
11.1.2 CPAP Humidifier 46
11.1.3 CPAP Masks 47
11.1.4 CPAP Other Accessories 48
12. MARKET INSIGHTS BY APPLICATION 50
12.1 General Overview 50
12.1.1 Sleep Apnea 51
12.1.2 COPD 52
12.1.3 Others Diseases 53
13. MARKET INSIGHTS BY END-USER 55
13.1 General Overview 55
13.1.1 Hospitals & Clinics 56
13.1.2 Home Care 56
13.1.3 Others (Sleep laboratories) 58
14. MARKET INSIGHTS BY REGION 59
14.1 General Overview 59
14.1.1 North America CPAP Device Market 61
14.1.1.1 United States CPAP Device Market 64
14.1.1.1.1 Current US population is 331 million people 65
14.1.1.2 Canada CPAP Device Market 67
14.1.1.3 Rest of North America CPAP Device Market 71
14.1.2 Europe CPAP Device Market 74
14.1.2.1 Germany CPAP Device Market 78
14.1.2.2 Russia CPAP Device Market 81
14.1.2.3 Spain CPAP Device Market 83
14.1.2.4 France CPAP Device Market 86
14.1.2.5 United Kingdom CPAP Device Market 89
14.1.2.6 Rest of Europe CPAP Device Market 92
14.1.3 Asia-Pacific CPAP Device Market 94
14.1.3.1 Japan CPAP Device Market 97
14.1.3.2 China CPAP Device Market 100
14.1.3.3 India CPAP Device Market 103
14.1.3.4 Australia CPAP Device Market 106
14.1.3.5 Rest of APAC CPAP Device Market 109
14.1.4 Rest of World CPAP Device Market 112
15. COMPETITIVE SCENARIO 115
15.1 Competitive Landscape 115
15.1.1 Market Share of Key Players in CPAP Device Market, 2019 115
16. TOP COMPANY PROFILES 116
16.1 3B Medical, Inc. 116
16.1.1 Key Facts 116
16.1.2 Business Description 116
16.1.3 Key Product/Services Offerings 117
16.1.4 Growth Strategy 117
16.1.5 SWOT Analysis 118
16.1.6 Recent Developments 118
16.1.6.1 Product Launches 118
16.1.6.2 Partnerships 119
16.1.6.3 Business Expansions and Investment 119
16.1.6.4 Mergers and Acquisitions 119
16.2 Philips Respironics 120
16.2.1 Key Facts 120
16.2.2 Business Description 120
16.2.3 Key Product/Services Offerings 120
16.2.4 Growth Strategy 120
16.2.5 SWOT Analysis 121
16.2.6 Key Financials 122
16.2.6.1 Revenue Split, by Region and Segment 123
16.2.7 Recent Developments 124
16.2.7.1 Product Launch 124
16.2.7.2 Partnerships 124
16.3 Nidek medical 125
16.3.1 Key Facts 125
16.3.2 Business Description 125
16.3.3 Key Product/Services Offerings 125
16.3.4 Growth Strategy 125
16.3.5 SWOT Analysis 126
16.4 ResMed 127
16.4.1 Key Facts 127
16.4.2 Business Description 127
16.4.3 Key Product/Services Offerings 128
16.4.4 Growth Strategy 128
16.4.5 SWOT Analysis 129
16.4.6 Key Financials 130
16.4.6.1 Revenue Split, by Region and Segment 131
16.4.7 Recent Developments 131
16.4.7.1 Product Launches 131
16.4.7.2 Partnerships 132
16.4.7.3 Mergers and Acquisitions 132
16.5 Fisher and Paykel Healthcare 133
16.5.1 Key Facts 133
16.5.2 Business Description 133
16.5.3 Key Product/Services Offerings 134
16.5.4 Growth Strategy 134
16.5.5 SWOT Analysis 135
16.5.6 Key Financials 136
16.5.6.1 Revenue Split, by Region and Segment 137
16.5.7 Recent Developments 137
16.5.7.1 Product Launch 137
16.5.7.2 Partnerships 138
16.6 Teijin Pharma Limited 139
16.6.1 Key Facts 139
16.6.2 Business Description 139
16.6.3 Key Product/Services Offerings 139
16.6.4 Growth Strategy 139
16.6.5 SWOT Analysis 140
16.6.6 Key Financials 141
16.6.6.1 Revenue Split, by Region and Segment 142
16.6.7 Recent Developments 143
16.6.7.1 Partnerships 143
16.6.7.2 Mergers and Acquisitions 143
16.7 Drive DeVilbiss Healthcare 144
16.7.1 Key Facts 144
16.7.2 Business Description 144
16.7.3 Key Product/Services Offerings 144
16.7.4 Growth Strategy 145
16.7.5 SWOT Analysis 146
16.7.6 Recent Developments 147
16.7.6.1 Product Launch 147
16.7.6.2 Partnerships 147
16.8 Koike Medical 148
16.8.1 Key Facts 148
16.8.2 Business Description 148
16.8.3 Key Product/Services Offerings 149
16.8.4 Growth Strategy 150
16.8.5 SWOT Analysis 151
16.9 BMC Medical Co., Ltd. 152
16.9.1 Key Facts 152
16.9.2 Business Description 152
16.9.3 Key Product/Services Offerings 152
16.9.4 Growth Strategy 152
16.9.5 SWOT Analysis 153
16.9.6 Recent Developments 154
16.9.6.1 Business Expansions and Investment 154
16.10 Fosun Pharma 155
16.10.1 Key Facts 155
16.10.2 Business Description 156
16.10.3 Key Product/Services Offerings 156
16.10.4 Growth Strategy 157
16.10.5 SWOT Analysis 158
16.10.6 Key Financials 159
16.10.6.1 Revenue Split, by Region and Segment 160
16.10.7 Recent Developments 161
16.10.7.1 Business Expansions and Investment 161
16.10.7.2 Mergers and Acquisitions 161
TABLE 2 Comparison of CPAP and Weight Loss for the Treatment of OSA 35
TABLE 3 Top Product Launches 35
TABLE 4 Top Partnerships 37
TABLE 5 Top Mergers& Acquisitions 38
TABLE 6 Top Business Expansions, Investment and Divestitures 39
TABLE 7 Arterial oxygen saturation (Sa,O2) and time spent at a Sa,O2 of ˂90% during treatment nights 43
TABLE 8 3B Medical, Inc. Company Key Facts 116
TABLE 9 Product segmentation of 3B Medical, Inc. 117
TABLE 10 3B Medical, Inc. Growth Strategy 117
TABLE 11 3B Medical, Inc. Product Launches 118
TABLE 12 3B Medical, Inc. Partnerships 119
TABLE 13 3B Medical, Inc. Business Expansions, Investment and Divestitures 119
TABLE 14 3B Medical, Inc. Mergers and Acquisitions 119
TABLE 15 Philips Respironics Key Facts 120
TABLE 16 Product segmentation of Philips Respironics 120
TABLE 17 Philips Respironics Growth Strategy 120
TABLE 18 Philips Respironics Product Launch 124
TABLE 19 Philips Respironics Partnerships 124
TABLE 20 Nidek medical Key Facts 125
TABLE 21 Product segmentation of Nidek medical 125
TABLE 22 Nidek medical Growth Strategy 125
TABLE 23 ResMed Key Facts 127
TABLE 24 ResMed Ownership Structure 127
TABLE 25 Product segmentation of ResMed 128
TABLE 26 ResMed Growth Strategy 128
TABLE 27 ResMed Product Launches 131
TABLE 28 ResMed Partnerships 132
TABLE 29 ResMed Mergers and Acquisitions 132
TABLE 30 Fisher and Paykel Healthcare Key Facts 133
TABLE 31 Fisher and Paykel Healthcare Ownership Structure 133
TABLE 32 Product segmentation of Fisher and Paykel Healthcare 134
TABLE 33 Fisher and Paykel Healthcare Growth Strategy 134
TABLE 34 Fisher and Paykel Healthcare Product Launch 137
TABLE 35 Fisher and Paykel Healthcare Partnerships 138
TABLE 36 Teijin Pharma Limited Key Facts 139
TABLE 37 The product segmentation of Teijin Pharma Limited 139
TABLE 38 Teijin Pharma Limited Growth Strategy 139
TABLE 39 Teijin Pharma Limited Partnerships 143
TABLE 40 Teijin Pharma Limited Mergers and Acquisitions 143
TABLE 41 Drive DeVilbiss Healthcare Key Facts 144
TABLE 42 Product segmentation of Drive DeVilbiss Healthcare 144
TABLE 43 Drive DeVilbiss Healthcare Growth Strategy 145
TABLE 44 Drive DeVilbiss Healthcare Product Launch 147
TABLE 45 Drive DeVilbiss Partnerships 147
TABLE 46 Koike Medical Key Facts 148
TABLE 47 Product segmentation of Koike Medical 149
TABLE 48 Koike Medical Growth Strategy 150
TABLE 49 BMC Medical Co., Ltd. Key Facts 152
TABLE 50 Product segmentation of BMC Medical Co., Ltd. 152
TABLE 51 BMC Medical Co., Ltd. Growth Strategy 152
TABLE 52 BMC Medical Co., Ltd. Business Expansions, Investment and Divestitures 154
TABLE 53 Fosun Pharma Key Facts 155
TABLE 54 Fosun Pharma Ownership Structure 155
TABLE 55 Product segmentation of Fosun Pharma 156
TABLE 56 Fosun Pharma Growth Strategy 157
TABLE 57 Fosun Pharma Business Expansions, Investment and Divestitures 161
TABLE 58 Fosun Pharma Mergers and Acquisitions 161
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
